Active	Status	Sponsor type	Region	Phase	Filter
7 Active 4 Inactive 11 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Gitelman, Stephen
NCT05743244: Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)	Recruiting	2	78	US	Abrocitinib 200 MG Oral Tablet, CIBINQO, Ritlecitinib, Placebo	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Pfizer	Diabetes Mellitus, Type 1	06/26	06/27
TOPPLE T1D, NCT04279613: A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041	Completed	1	47	US	NNC0361-0041, Placebo	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Novo Nordisk A/S	Type I Diabetes	08/23	04/24